Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy

American Journal of Perinatology

Volumn 20, Issue 1, 2003, Pages 17-23

  Ogunyemi, Dotun ^a,b,c   Cuellar, Francisco ^c   Ku, Wayne ^d   Arkel, Yale ^d  

^a KING DREW MEDICAL CENTER   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

Antiphospholipid antibodies; Inherited thrombophilia; Lipoprotein A; Pregnancy; Venous thromboembolism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; HOMOCYSTEINE; LIPOPROTEIN A; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0037243133     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37947     Document Type: Article

References (26)

1. Rosendaal FR. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis. Thromb Haemost 1997;78:1-6
2. Laros R. Thromboembolism in pregnancy. ACOG Educational bulletin 1997;234
3. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-1173
4. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258-1265
5. Ogunyemi D. Venous thrombosis in pregnancy. Female patient 2000;25:70-77
6. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chemist 1997; 43:1678-1683
7. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134
8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703
9. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocystenemia as a risk factor for deep venous thrombosis. N Engl J Med 1996;33:759-762
10. Arruda VR, von Zuben PM, Chiaparini LC, et al. The mutation ALA677 in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Hemost 1997;77:818-821
11. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-1353
12. Djurovic S, Berg K. Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic disease. Clin Genet 1997;52:281-292
13. Harris ED. Lipoprotein (a): a predictor of atherosclerotic disease. Nutr Rev 1997;55:61-64
14. Kuperminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl Med 1999;340:9-13
15. Ogunyemi D. The association of factor-V Leiden mutation and acquired antibodies with obstetrical complications. Am J Obstet Gynecol; SPO abstracts 1999;180:481
16. Lubencho LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26-42 weeks. Pediatrics 1966;37:403-408
17. Dilley A, Austin H, El-Jamil M, et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 2000;183:1271-1277
18. Grandone E, Margaglione M, Colaizzo D, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998;179:1324-1328
19. Gerhardt A, Scharf R, Eberhard B, et al. Prothrombin and Factor V Mutations in Women with a History of Thrombosis during Pregnancy and the Puerperium. N Engl J Med 2000;342:374-380
20. Gharavi AE, Pierangeli SS, Levy RA, Harris EN. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 2001;44:11-19
21. Leeda M, Riyazi N, de Vries J, et al. Effects of folic acid and vitamin B6 supplementation on women with Hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998;179:135-139
22. Wang J, Mimuro S, Lahoud R, et al. Elevated levels of lipoprotein (a) in women with preeclampsia. Am J Obstet Gynecol 1998;178:146-149
23. Husby H, Schjetlein R, Nesheim B, Berg K. High levels of Lp(a) lipoprotein in a family with severe preeclampsia. Clin Genet 1996;50:47-49
24. Leerink CB, de Vries C, van der Klis F. Elevated levels of serum lipoprotein (a) and apolipoprotein (a) phenotype are not related to preeclampsia. Acta Obstet Gynecol Scand 1997;76:625-628
25. Szczepanski M, Bauer A, Gardas A, Duchinski T. Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss. Int J Obstet Gynecol 1998;61:39-44
26. Berg K, Roade B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1994;46:52-56